The Crystal Structure of Human Soluble CD14 Reveals a Bent Solenoid with a Hydrophobic Amino-Terminal Pocket

Human monocyte differentiation Ag CD14 is a pattern recognition receptor that enhances innate immune responses to infection by sensitizing host cells to bacterial LPS (endotoxin), lipoproteins, lipoteichoic acid, and other acylated microbial products. CD14 physically delivers these lipidated microbial products to various TLR signaling complexes that subsequently induce intracellular proinflammatory signaling cascades upon ligand binding. The ensuing cellular responses are usually protective to the host but can also result in host fatality through sepsis. In this work, we have determined the x-ray crystal structure of human CD14. The structure reveals a bent solenoid typical of leucine-rich repeat proteins with an amino-terminal pocket that presumably binds acylated ligands including LPS. Comparison of human and mouse CD14 structures shows great similarity in overall protein fold. However, compared with mouse CD14, human CD14 contains an expanded pocket and alternative rim residues that are likely to be important for LPS binding and cell activation. The x-ray crystal structure of human CD14 presented in this article may foster additional ligand-bound structural studies, virtual docking studies, and drug design efforts to mitigate LPS-induced sepsis and other inflammatory diseases.

[1]  J. Silver,et al.  Biochemistry and expression of myelomonocytic antigens. , 1986, Journal of immunology.

[2]  S. Akira,et al.  Discrimination of bacterial lipoproteins by Toll-like receptor 6. , 2001, International immunology.

[3]  T. Kirkland,et al.  The N-terminal half of membrane CD14 is a functional cellular lipopolysaccharide receptor , 1996, Infection and immunity.

[4]  F. Re,et al.  Specific High Affinity Interactions of Monomeric Endotoxin·Protein Complexes with Toll-like Receptor 4 Ectodomain* , 2007, Journal of Biological Chemistry.

[5]  A. McPherson,et al.  Current approaches to macromolecular crystallization. , 1990, European journal of biochemistry.

[6]  Masakatsu Kamiya,et al.  Structural principles of leucine‐rich repeat (LRR) proteins , 2003, Proteins.

[7]  F. Peri,et al.  A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity , 2012, ChemMedChem.

[8]  R. Menzel,et al.  Structures in Bacillus subtilis Are Recognized by CD14 in a Lipopolysaccharide Binding Protein-Dependent Reaction , 1999, Infection and Immunity.

[9]  D. Golenbock,et al.  Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products* , 1999, The Journal of Biological Chemistry.

[10]  S. Nomura,et al.  Purification and characterization of human soluble CD14 expressed in Pichia pastoris. , 2003, Protein expression and purification.

[11]  D L Simmons,et al.  Monocyte antigen CD14 is a phospholipid anchored membrane protein. , 1989, Blood.

[12]  Anil Verma,et al.  Lysine Methylation as a Routine Rescue Strategy for Protein Crystallization , 2006, Structure.

[13]  S. Goyert,et al.  The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. , 1988, Journal of immunology.

[14]  Jennifer L. Martin,et al.  Post-crystallization treatments for improving diffraction quality of protein crystals. , 2005, Acta crystallographica. Section D, Biological crystallography.

[15]  S. Wright,et al.  Catalytic Properties of Lipopolysaccharide (LPS) Binding Protein , 1996, The Journal of Biological Chemistry.

[16]  R. Jerala,et al.  Expression and refolding of functional fragments of the human lipopolysaccharide receptor CD14 in Escherichia coli and Pichia pastoris. , 1999, Protein expression and purification.

[17]  A. Kallies,et al.  Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. , 1996, Journal of immunology.

[18]  J. Mathison,et al.  Structure-Function Analysis of CD14 as a Soluble Receptor for Lipopolysaccharide* , 2000, The Journal of Biological Chemistry.

[19]  A. McMichael Leucocyte typing III : white cell differentiation antigens , 1987 .

[20]  Roger L. Williams,et al.  The effects of neutral detergents on the crystallization of soluble proteins , 1986 .

[21]  A. McPherson Use of polyethylene glycol in the crystallization of macromolecules. , 1985, Methods in Enzymology.

[22]  R. Ulevitch,et al.  Structure and function of lipopolysaccharide binding protein. , 1990, Science.

[23]  M. L. Le Beau,et al.  The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. , 1988, Science.

[24]  Hayyoung Lee,et al.  The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.

[25]  G. Vereb,et al.  Fusion of the Fc part of human IgG1 to CD14 enhances its binding to gram-negative bacteria and mediates phagocytosis by Fc receptors of neutrophils. , 2012, Immunology letters.

[26]  M. S. Rangel-Frausto Sepsis: still going strong. , 2005, Archives of medical research.

[27]  R. Ulevitch,et al.  Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum , 1986, The Journal of experimental medicine.

[28]  Hayyoung Lee,et al.  Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran , 2007, Cell.

[29]  S. Goyert,et al.  Nucleotide sequence of the gene encoding the monocyte differentiation antigen, CD14. , 1988, Nucleic acids research.

[30]  Y. Satow,et al.  Crystal Structures of Human MD-2 and Its Complex with Antiendotoxic Lipid IVa , 2007, Science.

[31]  Sung-Hou Kim,et al.  Sparse matrix sampling: a screening method for crystallization of proteins , 1991 .

[32]  M. Wurfel,et al.  Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. , 1997, Journal of immunology.

[33]  B. Lorber,et al.  Additives for the crystallization of proteins and nucleic acids , 1999 .

[34]  R. Menzel,et al.  Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. , 1997, European journal of biochemistry.

[35]  T. Kirkland,et al.  CD14 Is a Cell-activating Receptor for Bacterial Peptidoglycan* , 1996, The Journal of Biological Chemistry.

[36]  R. Salomão,et al.  Bacterial Sensing, Cell Signaling, and Modulation of the Immune Response During Sepsis , 2012, Shock.

[37]  Zaida Luthey-Schulten,et al.  MultiSeq: unifying sequence and structure data for evolutionary analysis , 2006, BMC Bioinformatics.

[38]  Yoshinori Nagai,et al.  MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.

[39]  J. Thornton,et al.  Helix geometry in proteins. , 1988, Journal of molecular biology.

[40]  M. Wurfel,et al.  Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 , 1994, The Journal of experimental medicine.

[41]  D. Golenbock,et al.  The Differential Impact of Disulfide Bonds and N-Linked Glycosylation on the Stability and Function of CD14* , 2008, Journal of Biological Chemistry.

[42]  M. Brenner Leucocyte Typing III. White Cell Differentiation Antigens , 1988 .

[43]  T. Kirkland,et al.  A Region of Human CD14 Required for Lipopolysaccharide Binding (*) , 1995, The Journal of Biological Chemistry.

[44]  B. Costa,et al.  Glycolipids and benzylammonium lipids as novel antisepsis agents: synthesis and biological characterization. , 2009, Journal of medicinal chemistry.

[45]  S. Paik,et al.  Crystal Structure of CD14 and Its Implications for Lipopolysaccharide Signaling*♦ , 2005, Journal of Biological Chemistry.

[46]  R. Munford,et al.  Endotoxin-binding Proteins Modulate the Susceptibility of Bacterial Endotoxin to Deacylation by Acyloxyacyl Hydrolase* , 2007, Journal of Biological Chemistry.

[47]  Song Jiang,et al.  Human TLRs 10 and 1 Share Common Mechanisms of Innate Immune Sensing but Not Signaling , 2010, The Journal of Immunology.

[48]  Hidehiko Sano,et al.  CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll‐like receptors 2 and 1 without binding to the complex , 2006, Cellular microbiology.

[49]  J. Gegner,et al.  Lipopolysaccharide Binding Protein-mediated Complexation of Lipopolysaccharide with Soluble CD14 (*) , 1995, The Journal of Biological Chemistry.

[50]  J. Weiss,et al.  Isolation of Monomeric and Dimeric Secreted MD-2 , 2008, Journal of Biological Chemistry.

[51]  S. Opal,et al.  Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? , 1999, Critical care medicine.

[52]  R. Tapping,et al.  Binding of Bacterial Peptidoglycan to CD14* , 1998, The Journal of Biological Chemistry.

[53]  T. Kirikae,et al.  Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  J. Bajorath,et al.  Identification of CD14 residues involved in specific lipopolysaccharide recognition , 1997, Infection and immunity.

[55]  G. Núñez,et al.  ML -- a conserved domain involved in innate immunity and lipid metabolism. , 2002, Trends in biochemical sciences.

[56]  R. Ulevitch,et al.  Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[57]  L. Narhi,et al.  CD14: Physical Properties and Identification of an Exposed Site That Is Protected by Lipopolysaccharide (*) , 1995, The Journal of Biological Chemistry.

[58]  N. Gay,et al.  A Dimer of the Toll-Like Receptor 4 Cytoplasmic Domain Provides a Specific Scaffold for the Recruitment of Signalling Adaptor Proteins , 2007, PloS one.

[59]  J. Weiss,et al.  Transfer of Monomeric Endotoxin from MD-2 to CD14 , 2007, Journal of Biological Chemistry.

[60]  J. Silver,et al.  Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. , 1996, Immunity.

[61]  Liping Yu,et al.  Evidence of a specific interaction between new synthetic antisepsis agents and CD14. , 2009, Biochemistry.

[62]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[63]  Thomas C. Mitchell,et al.  The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4 , 2007, Science.

[64]  L. Kline,et al.  Phagocytosis of Gram‐negative bacteria by a unique CD14‐dependent mechanism , 1997, Journal of leukocyte biology.

[65]  S. Wright,et al.  Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. , 1997, The Journal of clinical investigation.

[66]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[67]  D. Golenbock,et al.  Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. , 1996, Journal of immunology.

[68]  M. Kelley,et al.  Identification of a Lipopolysaccharide Binding Domain in CD14 between Amino Acids 57 and 64 (*) , 1995, The Journal of Biological Chemistry.

[69]  R. Jack,et al.  Both membrane‐bound and soluble forms of CD14 bind to Gram‐negative bacteria , 1995, European journal of immunology.

[70]  M. Koch,et al.  Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. , 2000, European journal of biochemistry.

[71]  R. Kim,et al.  Optimum solubility (OS) screening: an efficient method to optimize buffer conditions for homogeneity and crystallization of proteins. , 2004, Acta crystallographica. Section D, Biological crystallography.

[72]  M. Kelley,et al.  Identification of a Domain in Soluble CD14 Essential for Lipopolysaccharide (LPS) Signaling but Not LPS Binding (*) , 1995, The Journal of Biological Chemistry.

[73]  Koichi Fukase,et al.  Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2 , 2012, Proceedings of the National Academy of Sciences.

[74]  Thomas E. Creighton,et al.  Stability of alpha-helices , 1987, Nature.

[75]  R. Tapping,et al.  Cellular Binding of Soluble CD14 Requires Lipopolysaccharide (LPS) and LPS-binding Protein* , 1997, The Journal of Biological Chemistry.

[76]  Elspeth Garman,et al.  'Cool' crystals: macromolecular cryocrystallography and radiation damage. , 2003, Current opinion in structural biology.

[77]  A. Tomasz,et al.  CD14 is a pattern recognition receptor. , 1994, Immunity.

[78]  David A. Johnson,et al.  Soluble CD14 Truncated at Amino Acid 152 Binds Lipopolysaccharide (LPS) and Enables Cellular Response to LPS (*) , 1995, The Journal of Biological Chemistry.

[79]  D. Golenbock,et al.  Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. , 1991, The Journal of biological chemistry.

[80]  M. Volta,et al.  Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay. , 1998, Journal of immunology.

[81]  K. Fukase,et al.  Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. , 2001, International immunology.

[82]  H. Engelmann,et al.  The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms. , 1996, European journal of biochemistry.

[83]  J. Elder,et al.  Endoglycosidases from Flavobacterium meningosepticum application to biological problems. , 1989, Methods in enzymology.

[84]  J. Silver,et al.  Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. , 1994, Journal of immunology.

[85]  R. Tapping,et al.  Soluble CD14-mediated cellular responses to lipopolysaccharide. , 2000, Chemical immunology.

[86]  H. Northoff,et al.  Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14. , 1998, Infection and immunity.

[87]  B. Lindner,et al.  Newer aspects of the chemical structure and biological activity of bacterial endotoxins. , 1985, Progress in clinical and biological research.

[88]  N. Coussens,et al.  Isolation of an endotoxin–MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[89]  C. Whitfield,et al.  Lipopolysaccharide endotoxins. , 2002, Annual review of biochemistry.

[90]  L. Kremer,et al.  Identification by surface plasmon resonance of the mycobacterial lipomannan and lipoarabinomannan domains involved in binding to CD14 and LPS‐binding protein , 2007, FEBS letters.

[91]  Bin Chen,et al.  Solution NMR studies provide structural basis for endotoxin pattern recognition by the innate immune receptor CD14. , 2008, Biochemical and biophysical research communications.

[92]  Elliott Bennett-Guerrero,et al.  Structure and function of lipopolysaccharides. , 2002, Microbes and infection.

[93]  V. Lopez,et al.  Purification of soluble CD14 fusion proteins and use in an electrochemiluminescent assay for lipopolysaccharide binding. , 2007, Protein expression and purification.

[94]  D. Rossignol,et al.  Inhibition of endotoxin response by synthetic TLR4 antagonists. , 2004, Current topics in medicinal chemistry.

[95]  M. Muroi,et al.  Structural Regions of MD-2 That Determine the Agonist-Antagonist Activity of Lipid IVa* , 2006, Journal of Biological Chemistry.

[96]  Ping-yuan Wang,et al.  Phosphatidylinositides Bind to Plasma Membrane CD14 and Can Prevent Monocyte Activation by Bacterial Lipopolysaccharide* , 1998, The Journal of Biological Chemistry.